and of concomitant disease or other drug therapy. In addition, as with other products containing beta 2-agonists, special caution should be observed when using Advair HFA in geriatric patients who ...

Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...

GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved ...

Generic inhalers can cost as little as $30. Notably, GSK said it recently reduced the list price of Advair HFA by an average ...

Looking ahead, Cipla aims to file its generic Advair product application from an alternative site by mid-FY 2025, which could gain approval towards end of next fiscal year if everything goes ...